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Impact of Sugar on Vision
Grace Ogbonna, Rosemary Ehigbo and Ogbonna Hannah
Abstract
Sugar forms an integral part of the human body, and contributes to normal 
body function. However, sugar in high quantities can be detrimental to the body 
especially to the eye. In the normal concentration, sugar in the form of glucose is 
found in the aqueous humour, and tears, and serves to provide nourishment to 
the avascular cornea, and lens respectively. Sugar at this stage may also be used to 
determine the post mortem interval of a cadaver. However, when in excess as may 
be seen in patients with diabetes, sugar can cause oxidative stress to the cornea, 
lens, and retina resulting in cornea oedema, cataract, retinal aneurysm which can 
contribute significantly to the prevalence of low vision, and vision impairment.
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1. Introduction
Sugar forms an integral part of the human eye, and can be found in different 
parts of the eye including the tears, aqueous humour, and the lens. Its primary func-
tion in the eye includes; maintenance of the structural component of the eye, and 
the provision of nourishment to the surrounding structures of the eye wherein it is 
found. For instance, glucose found in the aqueous humour forms part of the required 
nourishment to the avascular lens, and cornea [1]. In the tears, sugar in the form of 
glucose forms part of the nutrients that supply the avascular cornea. The sugar in the 
vitreous is present as hyaluronic acid which is a molecular unit of glucusonite, and 
N-acetylglucosamine. Its function is to maintain the point of vitreous attachment to 
the retina. In general, sugar is important for the normal functioning of the human 
eye. In the lens, sugar is found as polysaccharides. Meyer et al [2] showed that there 
are at least three different polysaccharides in the cornea stroma - keratin sulfate, 
chondroitin-4-sulfate, and chondroitin, and may play a role in cornea healing.
Despite the role of sugar in maintaining the metabolic requirements of the human 
body, excessive sugar consumption can lead to high sugar concentration in blood 
circulation within the body system which can be detrimental to human health. 
Sustained high sugar level results in hyperglycaemia, and if left unchecked can result 
in Diabetes Mellitus. Diabetes mellitus is a group of metabolic diseases, character-
ized by chronic hyperglycaemia due to deficiency in the production, and/or usage of 
insulin. Diabetes mellitus can occur as either Type 1 (due to poor secretion of insulin) 
or Type 2 (due to poor usage of insulin for glucose metabolism).
Diabetes Mellitus presents with a myriad of ocular complications and has been 
identified as the leading cause of legal blindness globally. Complications secondary 
to diabetes affects almost every part of the eye and could result in diabetic reti-
nopathy, cataracts, glaucoma, keratopathy, dry eye syndrome, and so many others 
(Figure 1).
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In recent years, diabetes mellitus has become a serious public health concern 
as the number of diabetic patients worldwide has more than doubled over the last 
three decades. In 2010, 286 million people were said to be diabetic, and this was 
projected to increase to 439 million by 2030 [3]. As the prevalence of DM, duration, 
and onset increases, the number of patients with ocular complications due to the 
condition is also expected to increase.
2. Mechanism of action of the effect of hyperglycaemic on the eyes
The mechanism of action of hyperglycaemia on the eyes and the consequential 
damage to the eyes have been likened to that of the effect of ageing on the eye [4]. 
Various factors such as pro-inflammation, oxidative stress, glycosylated cross-
linkages, the formation of advanced glycelated end-products (AGE), vascular perme-
ability, vascular endothelial growth factor (VEGF), and epigenetic factors have been 
found to cause to ageing changes in the eye. Similarly, these factors have been impli-
cated in the development of ocular complications secondary to sustained increased 
sugar levels in the body [5–7].
Further, Insulin resistance as may be seen in diabetic patients has been associated 
with the repression of a Sirtuin 1(Sirt 1) [8], which is the gene responsible for the 
regulation of appetite in the geriatric population. Sirt 1 is also known as the anti-age-
ing gene due to its ability to alleviate oxidative stress [8–10]. Repression of Sirt 1 gene 
may lead to mitochondrial apoptosis, and in diabetic patients can also lead to diabetic 
retinopathy due to oxidative stress [8, 10, 11].
3. Sugar, and the lens: an overview
The human crystalline lens is the structure directly behind the iris, and in 
front of the vitreous humour [1]. The lens thickness and curvature allows it to 
Figure 1. 
Fundus picture of a proliferative diabetic retinopathy.
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contribute significantly to refraction [12]. It is also responsible for accommodation 
in non-presbyopic, and pre-presbyopic people. Its transparent nature allows for the 
passage of light to the retina. Physiologically, the lens contains 2/3 water, and 1/3 
protein (water-soluble and water-insoluble proteins) [13]. Water-soluble proteins 
are responsible for maintaining the lens optical properties. On the other hand, 
water-insoluble protein maintains cellular structures, architectural arrangement, 
and alignment.
The lens lacks blood vessel supplies to it and is therefore regarded as avascular. 
Due to the lack of blood vessels in the lens, it acquires most of its nutrition from the 
aqueous humour, through the aerobic glycolysis, or through the pentose phosphate 
pathway (sorbitol pathway). The sorbitol pathway is believed to be a pathway 
through which glucose, and galactose from the aqueous humour is absorbed into 
the lens [14]. When glucose is absorbed, it is reduced to sorbitol by the aldose 
reductase enzyme. Further to this, sorbitol is metabolized by the sorbitol dehy-
drogenase, whereas galacititol remains in the lens nearly not metabolized for a 
prolonged period. In diabetes, the increased presence of sugar in the blood results 
in increased glucose level in the aqueous, therefore bringing about increased sugar 
inflow into the lens through the sorbitol pathway [15]. Unfortunately, the sorbitol 
is produced faster than it is converted to fructose by the sorbitol dehydrogenase. 
This, therefore, means an increased amount of sorbitol in the lens. The prolonged 
presence of sorbitol in the lens results in increased intracellular fluid as a response 
to increased osmotic pressure, therefore causing the swelling of the lens material. 
Further, because sorbitol is polar, it is hardly removed from the lens through simple 
diffusion.
3.1 Sugar, and cataract
Sustained hyperglycaemia causes the inflow of sugar into the lens resulting in 
the swelling of the lens material. This also results in the loss of the lens structural 
arrangement (lens fibres), precipitation of the water-insoluble proteins, oxidation 
of the water-insoluble proteins, hardening of the lens fibres, formation of perma-
nent bonds, and eventually cataract.
Sugar induced cataract is a common occurrence, and a significant cause of 
visual impairment among diabetic patients. According to the Framingham study 
findings, diabetic patients under 65 are four times more likely to develop cataracts 
than their normal age mates. The onset of cataract in diabetes is often associated 
with fluctuations in the sugar level of a sufferer, and the cataract progresses rapidly 
once initiated. Even though the process of cataract formation in a diabetic patient is 
known, however, there is no known mechanism to delay its formation in the pres-
ence of Hyperglycaemic [16]. Nevertheless, cataract surgery is a recommended, and 
effective way of manageing diabetic cataracts.
Early cataract extraction in diabetic patients though recommended, should be 
approached with caution, and is advisable to be done with regulated blood sugar 
levels as healing may be delayed due to Hyperglycaemic [17, 18]. Although, a study 
in Nigeria reported no significant difference in the visual outcome of diabetic 
patients post-cataract when compared to age-matched nondiabetic controls, how-
ever, complications such as rubeosis, acceleration in the formation of retinopathy, 
post-operative inflammation,, and incidence of clinical, and angiographic cystoid 
oedema has been reported to occur more in diabetic patients following cataract 
extraction [19]. Given these complications, the preferred method of cataract extrac-
tion in diabetic patients is phacoemulsification as this has been associated with 
fewer complications, and better prognosis.
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3.2 Sugar, and refractive error
Refractive changes have been noted to occur in diabetic patients. A number  
of earlier clinical studies had reported an association between sustained hypergly-
caemia, and refractive shift towards increased myopia [12, 19, 20]. Myopic shift 
occurs when a diabetic patient experiences more myopia than the regular refractive 
error status. This happens due to an increase in the inflow of sugar into the lens 
through the sorbitol pathway catalysed by the aldose reductase activity [21, 22]. 
People with diabetes have been observed to have a higher prevalence of myopia 
compared to those without diabetes [23]. In a study conducted by Jacobsen et al 
[24] it was determined that the prevalence of myopia (spherical equivalent 0.5 D) 
was 53.3% among 252 type 1 diabetic patient age 16–26 years old. The relative risk 
of a myopic shift was determined to be 1.7 in patients aged 16–21 years, and 1.6 in 
patients with HbA1c above 8.8%. Insulin dosage was not related to myopia. Klein et 
al. [21] showed that persons of similar age with T1D were likely to be more myopic 
than those with T2D. In general, myopia associated with diabetes reverses when 
sugar control is instituted.
Although past studies had reported a myopic shift in refractive status following 
an increase in sugar level, however, recent studies have also noted a hyperopic shift 
associated with glycaemic control [25, 26]. Hyperopic shift following hyperglycae-
mia control has been reported to occur when glucose levels fall a few days or weeks 
after the initiation of glycaemic control [12, 27]. This hyperopia was associated with 
increased lens thickness, and a decrease in anterior chamber depth [22]. Lin et al 
[12] reported the development of hyperopia in 4 men and 1 woman who was treated 
with insulin. According to their report, the hyperopia peaked at 11.7 days after 
initiation of glycaemic control and tapered off at 64.0 days after treatment initia-
tion. From this it can be deduced that institution of treatment in diabetic patients 
is often followed by two refractive changes; one involving a rapid refractive change 
towards the direction of hyperopic, and the other is a gradual change to the patient’s 
normal refractive status.
In general, both myopic, and hyperopic shifts are transient, and patients’ refrac-
tive status gradually returns to the baseline values a few days or weeks after sugar 
stabilizes. Thus, it can be said that both myopic, and hyperopic shift may occur with 
changes in sugar levels in a hyperglycemic patient [25]. Hence, change in prescrip-
tion glasses should be approached with caution as glasses prescribed during this 
time will only be durable during the said sugar fluctuations [28].
3.3 Sugar, and accommodation
Several studies have reported on biometric changes such as lens thickening, 
increase in the lens surface curvature and a decrease in the refractive index sec-
ondary to diabetes [29]. According to Mathebula, and Makunyane “people with 
diabetes have accelerated age-related biometric ocular changes compared to people 
without diabetes” [4]. Elevated sugar levels in pre-presbyopic patients have been 
associated with a reduction in the amplitude of accommodation. According to 
Huntjens and O’Donnell, amplitude of accommodation is lower in people living 
with Type I patients than that of their non-diabetic age-matched, even in the 
absence of non-detectable retinal damage [25].
Amplitude of accommodation is important for maintaining images on the retina 
while doing near work. A reduction in amplitude of accommodation means that 
the near point becomes receded, and a patient will have difficulties reading things 
at near as seen in presbyopic patients. This has unfortunately been found in pre-
presbyopic diabetic patients who show signs of presbyopia earlier than their age 
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match nondiabetic counterparts. The effect of hyperglycaemia on the accommoda-
tive system may be due to changes in lens glucose metabolism, ischemic hypoxia 
on the oculomotor nerve, and ciliary muscles. Some studies have noted that the 
longer the duration of diabetes, the more likely the reduction in the amplitude of 
accommodation.
4. Sugar, and the cornea
The cornea is a superficial organ most affected by high sugar levels [30]. The 
impact of sugar on the cornea varies with its level and duration, and may underpin 
specific systemic complications that may be associated with diabetes. At normal 
glycaemic levels, sugar serves as one of the dissolved nutrients in the tears, and 
aqueous humour that nourishes the cornea. Sugar is also found in the cornea stroma 
in the form of polysaccharides (glycosaminoglycan GAG) [31]. GAG reduces 
the effects of diffraction when light is directed towards the eye. Chondroitin 
sulphate an element that plays a role in cornea wound healing is also made from 
polysaccharides.
However, in diabetes, sugar promises to be detrimental to the anatomical and 
physiological wellbeing of the cornea. Structural components such as the epi-
thelium, the nerves, immune cells, and the endothelium of the cornea are often 
negatively affected. Sustained hyperglycaemia reduces cornea sensitivity and 
innervation due to peripheral neuropathy. These nerve alterations occur all over the 
cornea including at the cornea scleral junction (limbal region) where new epithelial 
cells are formed [31]. When there is a reduction in corneal sensitivity, affected 
patients experiences various symptoms, and in most cases become susceptible to 
further damages to the eye. Reduction in corneal sensitivity has been identified as a 
predictor for the development of peripheral neuropathy in diabetic patients.
Other cornea complications such as corneal infections, ulcers, and oedema have 
been reported in diabetic patients with poorly controlled glycaemic levels. Sugar 
induced cornea swelling increases the fragility of the cornea epithelium and can 
result in stroma oedema [32]. This for unknown reasons affects the stromal collagen 
bundles and increases corneal autofluorescence level. The variation between the 
normal fluorescence level and increased autofluorescence in the corneal may be an 
indicator of changed corneal metabolism due to impaired corneal mitochondria 
metabolism. Corneal fluorescence may also be an indicator of a pathological break-
down of the blood-aqueous- barrier as may be seen in patients with proliferative 
diabetic retinopathy.
Sustained hyperglycaemic levels in the body also increases the chances of cor-
neal erosions, persistent epithelial defects, corneal endothelial damage, and dry eye 
[6, 22, 32]. With Sustained hyperglycaemia the cornea faces difficulties with wound 
healing, and most times there is incomplete wound healing, thus small corneal 
erosions become persistent as wound healing is delayed. Delayed wound healing 
has been linked to a reduction in cornea epithelium regeneration secondary to a 
decrease in cornea sensitivity, which occurs as a result of peripheral neuropathy [6]. 
linked Further, because the ability of the cornea to ward off infections is reduced, 
infections like fungal keratitis occurs and remains recurrent [33].
5. Sugar, and the lids, and conjunctiva
The lids and conjunctiva are tissues in the body that protects the eye against 
external invaders. Sustained high blood sugar level increases the susceptibility 
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of the human system to bacterial infection. In the lid, this susceptibility leads 
to a recurrent bacterial infection which can lead to the formation of stye, and 
blepharitis.
High sugar and reduced insulin as is obtainable in diabetes pose damaging 
consequences to the meibomian gland. Like other sebaceous glands, insulin forms 
an essential component for the optimal functioning of the sebaceous glands and 
resistance or reduction in its absorption results in the dysfunction of the Meibomian 
gland. Similarly, sustained increase in sugar level brings about the lipolysis of adi-
pocytes, this, therefore, means that sustained sugar levels in the Meibomian gland 
will reduce the quality of the meibum secreted in the eye. Meibum is the secretion 
responsible for ensuring the liquid part of the tears (aqueous) does not overflow or 
evaporate, hence reduction in the quality of meibum would allow for tear evapora-
tion, bringing about dry eye effect in diabetic patients.
Similarly, the goblet cells found in the conjunctiva which are responsible for 
the production of the mucin layer of the tear film are often adversely affected with 
Hyperglycaemic. Diabetes also affects the conjunctival blood vessels in similar ways 
as it does to the retinal blood vessels [34]. In the conjunctiva, capillary loss, and 
microvascular dilatation had similarly been observed as a consequence of sustained 
hyperglycemia. Similarly, studies have reported on the tortuosity of conjunctival 
blood vessels.
6. Sugar, and dry eye
Dry eye is a disorder of the tear film which results in symptoms such as pain, 
burning, itchiness, stinging, grittiness, foreign body sensation, tearing, and ocular 
fatigue. Due to the multifactorial nature of dry eye onset, it has been referred to as 
a disease of the lacrimal function unit (LFU). The lacrimal function unit is made up 
of the cornea, lid, conjunctiva, Meibomian gland, the sensory, and the motor nerves 
which all work as a unit to maintain the tear film layer. Dry eye is a common experi-
ence in diabetic patients.
The occurrence of dry eye in a diabetic patient may be as a result of the negative 
effect of hyperglycaemia on any part of the lacrimal function unit. For instance, 
insufficient production of tears due to reduced cornea sensitivity secondary to 
autonomic neuropathy has been blamed as part of the reason for dry eye develop-
ment in diabetic patients [35]. Corneal sensitivity forms part of the neuronal 
loophole feedback mechanism for reflex tear secretion. Autonomic neuropathy 
affects the nerves that control the lacrimal gland secretion, bringing about a reduc-
tion in tears secretion, due to reduced corneal sensitivity. For instance, damage to 
the microvasculature of the lacrimal gland accompanied by autonomic neuropathy 
in diabetic patients often impairs lacrimation, therefore, resulting in dry eye 
symptoms in such a patient. The reduction in tear secretion accounts for the low 
Schirmer test result as may be seen in diabetic patients. It is noteworthy that once 
corneal peripheral neuropathy sets in, corneal sensitivity starts and the magnitude 
of reflex tear secretion is affected.
Also, dry eye may result due to a reduction in the population density of the 
goblet cells secondary to the effect of diabetes on the cells on the goblet cell func-
tion [22]. The goblet cells are responsible for the secretion of mucin which is the 
first layer of the tear film. The mucin layer is responsible for maintaining the tear 
film layer on the cornea to avoid the drying out of the cornea and maintaining its 
lustre. Therefore, a reduction in the density of the goblet cells will bring about a 
decrease in the secretion of the mucin layer, resulting in the inability of the tear film 
to remain stable on the cornea. Also, alongside the reduction in goblet cell density, 
7
Impact of Sugar on Vision
DOI: http://dx.doi.org/10.5772/intechopen.96325
there is an accompanying reduction in the ability of the mucin layer to “pickup-up’ 
the cytology impression necessary to maintain the tear film spreading, and stability 
on the cornea. These two factors (goblet cell density, and mucin sensitivity), have 
been cited to partly be responsible for the reduction in the tear break-up time.
Some retinal changes, and procedures have similarly been linked with dry eye 
in patients with prolonged, and sustained hyperglycaemia. Reduction in total tear 
secretion has been reported in patients with non-proliferative diabetic retinopathy. 
This on the other hand is relatively small in people without retinopathy. Also, 
pan-retinal photocoagulation has been suggested to increase dry eye syndrome in 
patients.
Dry eye symptoms in diabetic patients are often associated with longer duration 
of the disease; it may also be associated with glycaemic level (HBA1c) [36]. Further, 
poorly controlled glycaemic level has been associated with more symptoms of dry 
eye. The most frequently encountered dry eye disease symptoms in diabetic patients 
include itching, burning, and foreign body sensation. Detection of dry eye in a 
diabetic patient can be achieved through conducting a comprehensive eye examina-
tion, which among others should measure the volume of tears, and determine the 
quality of the tears. This can be achieved by running specific diagnostic tests such 
as the Tear Film Break-Up Time (TFBUT), fluoresce test, Schirmer test, and rose 
Bengal. Management of dry eye in patients with diabetes strongly revolves around 
glycaemic control, and healthy lifestyle.
7. Sugar, and the iris
Hyperglycaemia affects the iris in various ways. Morphologically, changes in the 
iris structure, vessels, pigment granules, and vacuolation of the pigment. The iris 
epithelium due to hyperglycaemia can experience depigmentation of the cells which 
often deposits on the corneal endothelium or is washed by the aqueous flow to the 
trabecular meshwork where it could block the outflow of aqueous from the mesh-
work, therefore resulting in the building of ocular tension (increased intraocular 
pressure). Also, Hyperglycaemic may cause rubeosis iridis (the formation abnormal 
blood vessels on the epithelial layer of the iris), a response that has been associated 
with ischaemia secondary to retinal capillary dropout.
Further, abnormal iris transilluminance has been reported to occur in type 
2 diabetes patients. This has been associated with short term retinopathy and is 
said to be an indicator or marker for rapidly progressive retinopathy in diabetes 
[37]. Similarly, ultrastructural changes have been reported in the regions of the 
sphincter, and dilator muscles of the iris, with more of the changes seen in the 
iris, this may explain why the pupil in diabetic patient’s experience miosis while in 
dark rooms.
8. Sugar, and the vitreous
In the presence of hyperglycaemia, the vitreous gel and vitreous interface 
experiences alterations which are often predictors to the development of diabetic 
retinopathy. Changes in the vitreous gel due to diabetic mellitus may include; 
increased collagen fibril cross-linking, accumulation of advanced glycation end 
products, liquidation of the vitreous gels, vitreous haemorrhage and alteration 
in the concentration of various proteins present in the vitreous [38, 39]. In some 
cases, there may also be the development of new vessel on the vitreous surface, this 
can happen in response to retinal ischemia and can result in a structural change in 
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the vitreous [40, 41]. The presence of severe non-clearing vitreous haemorrhage 
may be an indicator for the.
9. Sugar, and the retina
Sugar affects different layers of the retina, and in most cases is very detrimental, 
and can lead to blindness. Diabetic retinopathy is the most common cause of visual 
impairment in patients living with diabetes.
9.1 Sugar, and diabetic retinopathy
Diabetic retinopathy is a microvascular complication of diabetes. It is said to 
occur to some degree in almost all type 1 diabetic patients and in nearly 77% of 
people living with type 2 diabetes for more than 2 decades [7]. Its formation has 
been linked to hyperglycaemic induced electrolyte imbalance secondary to high 
aldose reductase levels in the retina [39]. The electrolyte imbalance leads to the 
loss of retinal endothelial cells and loss of vascular pericytes which are responsible 
for regulating the retinal vascular tone. Loss of endothelial cells results in the 
breakdown of the blood-retinal-barrier resulting in an increase in the vascular 
permeability. On the other hand, the loss of the pericytes results in vasodilation and 
the thickening of the capillary basement membrane all of which leads to microan-
eurysm (formation of small outpouchings from blood vessel walls) [42], a primary 
indicator of early retinopathy changes in diabetes [43].
There are different stages of diabetic retinopathy: mild non-proliferative diabetic 
retinopathy, pre-proliferative diabetic retinopathy, and proliferative diabetic retinop-
athy. According to the findings of the Wisconsin study, the prevalence of retinopathy 
in patients with diabetes increases from 2% to 97.5% in people with diabetes less than 
2 years, and 15 or more years respectively. Prevalence of proliferative retinopathy 
was notably at zero but increased with age to 4%, 25%, and 67% among diabetic 
patients who had lived with diabetes for 10 years, 15 years, and 35 years respectively. 
Proliferative diabetic retinopathy is the most complicated stage of diabetic retinopa-
thy and is often associated with other complications such as vitreous haemorrhage, 
tractional retinal detachment, combined tractional rhegmatogenous retinal detach-
ment, and severe fibrovascular proliferation.
Proliferative diabetic retinopathy is said to occur due to prolonged retinal 
ischemia secondary to Hyperglycaemic. Retinal ischemia leads to the production of 
angiogenic factors which are produced in an attempt for the retina to revascularize 
the hypoxic areas of the retina. Thus the release of angiogenic factors is the retinal 
way of seeking for a secondary means of transporting oxygen to the affected parts 
of the retina. After the formation of the angiogenic factor, there appears to be an 
interaction between the angiogenic factors, and the vascular endothelial growth 
factor (VEGF) thereby inducing the growth of new blood vessels (neovasculariza-
tion). The new vessels are fragile, and can easily rupture, but they proliferate persis-
tently. The proliferation of the new blood vessels is accompanied by varying degrees 
of fibrous tissue proliferation. Fibrous tissue proliferation into the vitreoretinal 
interface brings about the formation of fibrovascular membranes in the vitreoreti-
nal interface.
The fibrovascular tissues attach themselves to the vitreoretinal interface focally 
(at a point) or broadly (at different points). The point of attachment of the fibro-
vascular tissue to the vitreoretina exerts tractional forces at these points, therefore, 
pulling on the retina, and resulting in tractional retinal detachment.
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Although the duration and glycaemic control play a role in the development of 
retinopathy, genetics, and individual disparity contribute significantly to the devel-
opment and degree of retinopathy. Diabetic retinopathy has been cited to occur more 
globally in Latin Americans, and South Asians [5]. Clustering of diabetic retinopathy 
among people of similar ethnicity suggests that genetics could play a significant 
role in its development. The role of familial genetics in the development of diabetic 
retinopathy was demonstrated by Leslie and Pyke who found that 95% of concor-
dant type 2 diabetic twins versus 68% of concordant type 1 diabetic identical twins 
develop a similar degree of diabetic retinopathy. Also, siblings with diabetes have 
similar levels of diabetes when compared to other levels of retinopathies seen in non-
family members. Familial clustering for the risk of developing severe retinopathy to 
increase among those who have diabetic relatives with positive retinopathy with an 
odds ratio of 5.4 compared to those whose relatives do not have the retinopathy [44].
Further, the genes responsible for encoding the aldose reductase (ALR), Angio-
tensin-1-converting enzyme, endothelial nitric oxide synthase (eNOS), a receptor 
for advanced glycation end products (RAGE), and Vascular Endothelial Growth 
Factor (VEGF), has been implicated in the development of Diabetic retinopathy 
[44]. Also, evidence exist which suggest that low-grade inflammatory responses 
underlies the resultant vascular complications seen in diabetes retinopathy. This, 
therefore, implies that diabetic retinopathy is an inflammatory disease that results 
due to elevated systemic cytokines like TNF-a, and IL-1B, and elevated numbers of 
activated leukocytes circulating in the retinal blood vessels.
The role of angiotensin II in the formation of diabetic retinopathy has been 
well studied with most studies promoting possible retardation of the prolifera-
tion process seen in diabetic retinopathy through the use of drugs that blocks the 
renin-angiotensin system. This is because angiotensin II which promotes vascular 
remodelling, and proliferation can cause an increase in the growth of capillaries, 
and cell permeability, and oxidative stress which is common in the formation of 
diabetic retinopathy.
The role of vasodilators like nitric oxide has rather been inconclusive, and 
a matter of debate. While some researchers believe that nitric oxide could lead 
to retinal damage and death, some others believe that nitric oxide enzyme may 
be protective in the development of diabetic retinopathy. Also, the actions of 
Glucagon-Like-Peptide-1 (GLP-1) a 30-amino acid, which is a hormone produced 
in the intestine, and helps in regulating blood glucose has been found to play a 
protective role on the retinal cells via the reduction of oxidative stress on the retina, 
which is protective in the development of diabetic retinopathy [11]. The action of 
GLP-1 is often activated by SIRT1 an anti-ageing gene.
10. Sugar and the optic disc, and nerve
Sustained sugar level affects the optic nerve resulting in nerve abnormalities, for 
instance, the optic disc often experiences pronounced oxidative stress, ischaemia, 
and neurodegeneration which eventually results into loss of the retinal nerve fibre 
layer, and optic atrophy. Optic atrophy may occur due to the inability of the nerves 
to access nourishment secondary to hyperglycaemia. Optic atrophy secondary to 
hyperglycaemia is very common in diabetic patients who are in their fourth decade 
of life. Although this presents no symptoms, it requires constant monitoring as it 
may ensure to proliferative diabetic retinopathy.
Optic nerve atrophy may also occur as a result of damage following photocoagu-
lation treatment. This often shows a characteristics appearance that is abnormal 
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which may or may not be similar to glaucomatous damage [45]. This is due to nerve 
damage that may be associated with the destruction of the axons of the retinal gan-
glion cells following pan-retinal photocoagulation. Other causes of optic atrophy 
may include previous diabetic papilopathy, nonarteritic ischemic neuropathy, and 
multiple nerve fibre layer infarcts.
Neovascularization at the optic disc head may also occur especially in the prolif-
erative stage of diabetes. Although the formation of these vessels are mechanisms 
by which the eye seems to transport oxygen to areas without nourishment, however, 
the new vessels formed are both fragile, and vulnerable to rupture, hence presents a 
danger to the eye.
11. Diabetes induced maculopathy
Diabetes induced maculopathy is a common occurrence in people with diabetic 
retinopathy [41]. Its prevalence is often determined by the type of diabetes, the 
severity of diabetic retinopathy, and duration of the disease. Type 1 diabetic 
patients are less likely to develop maculopathy, than type 2 diabetic patients [40]. 
Also, the occurrence of maculopathy in type 1 diabetic patients is highly depen-
dent on the duration of the disease. Most of the patients with type 1 diabetes will 
rarely develop maculopathy before 8 years of the disease, with about 25–30% 
developing maculopathy after 20 years of the disease [41, 43]. About 3% of type 
2 diabetic patients with non-proliferative retinopathy will have macular oedema, 
whereas between 40%, and 70% of those with moderate, and proliferative 
retinopathy respectively would end up developing macular oedema. Among this 
population, nearly half of them will experience fovea involvement of the macula 
oedema [43].
12. Pupil involvement in diabetes
Pupillary involvement is a common occurrence in diabetic patients and has been 
suggested to be due to autonomic neuropathy secondary to degenerative changes 
at the nerve terminal. In the pupil, the autonomous nervous system regulates 
the sphincter, and dilator muscles which controls the pupillary response to light, 
accommodation, and drugs. Sustained high sugar level often results in autonomic 
neuropathy which meant that nerves lose their ability to respond or conduct 
sensations as they ought to. The occurrence of autonomic neuropathy results in 
partial denervation of mostly the dilator muscle of the pupil. This, therefore, 
implies different pupillary responses to normal pupillary stimulus diabetic patients 
will be affected. For instance, diabetic pupils have excessive miotic pupils in dim 
illumination, also diabetic pupils experience loss of light reflex, non-syphilitic-
Argy Robertson pupil has been reported. Further, variations in response to topical 
mydriatic agents have similarly been noted.
13. Sugar, and glaucoma
There are still conflicting opinions regarding the relationship between glaucoma 
and diabetes, however, the mechanism that leads to the autonomic dysfunction in 
the regulation of intraocular pressure, fluctuation of intraocular pressure, and the 
increased susceptibility of retinal ganglion cells to cell death can easily be rational-
ized [46]. According to Negi and Vernon [43], diabetic patients are at high risk 
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of developing higher intraocular pressures than their non-diabetic counterparts. 
Proliferative diabetes is one of the leading causes of neovascular glaucoma.
14. Sugar, and ophthalmoplegia
Ophthalmoplegia is a rare adverse effect of diabetes mellitus. It is often associ-
ated with multiple cranial nerve palsies affecting nerve III, IV, and VI. Patients with 
ophthalmoplegia secondary to diabetes often make a full recovery after 12 weeks 
of the onset of the condition [47]. A study by Kahtani et al. [48] reported ophthal-
moplegia to be more common in male than female diabetic patients. Medial squint 
and Ptosis have also been reported in patients with acute vasculitis due to diabetes 
mellitus.
15. Sugar, and low vision
Complications secondary to diabetes mellitus is the leading cause of blindness 
in developed countries [6, 40]. According to global estimates, 5% of the 37 million 
cases of blindness occur secondary to diabetic retinopathy [7]. However, not all 
cases of diabetic retinopathy results in blindness, some others cause low vision in 
affected patients.
Low vision as defined by World Health Organization (WHO), is the visual acu-
ity of less than 6/18 in the best-corrected eye of a patient. It can also be defined as 
the visual field of less than 10 degrees in a patient. There exists a strong relationship 
between complications resulting from sustained hyperglycaemia as seen in diabetes 
and low vision. Some of the complications resulting from hyperglycaemia brings 
about visual changes in sufferers which may eventually lead to low vision. Some 
visual changes that have been reported by hyperglycaemic patients include changes 
in Visual acuity, colour vision, contrast sensitivity, reduction in glare tolerance, and 
visual field all, of which affects a person’s quality of life.
15.1 Sugar, and visual acuity
Because visual acuity status is affected by the status of the retina, cornea, lens, 
and the anterior chamber, visual acuity is one of the visual functions that is heavily 
affected by hyperglycaemia at different stages of the disease. Visual acuity may be 
affected by the presence of Diabetic cataract, which reduces the clarity of the lens. 
Visual acuity may also be affected by the presence of retinopathy which results in 
irreversible damage in the visual threshold of the patient. Other causes of reduction 
in visual acuity in a diabetic patients patient may include macular oedema, corneal 
haze, variations in the refractive status of the eyes due to variations in glycaemic 
levels, and procedures such as photocoagulation for diabetic macular oedema [49].
15.2 Sugar, and colour vision
Acquired dyschromatopsia has been reported to be common in people living 
with type 2 diabetes. The Okubo colour study, conducted among type diabetic 
patients showed that there is an-increased-adjusted-odds (5.89) for the develop-
ment of colour vision impairment by type 2 diabetic compared with their age-
matched normal glycaemic peers [2]. Some studies have reported an increase in the 
incidence of acquired, non-sex-linked blue-yellow colour vision deficit in diabetic 
patients. According to a study by Melisa et al., the blue-yellow colour deficit is more 
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pronounced as diabetic retinopathy progresses, and is worse among patients who 
may have undergone laser treatment. The association between colour vision deficit 
and diabetes may be because diabetes irrespective of stage gradually affects the 
optic nerve as well as the retina, therefore resulting in abnormalities. Tan et al. also 
showed that more than 6 duration of type two diabetes may predispose patients to 
develop colour vision impairment [50].
15.3 Sugar and contrast sensitivity
Contrast sensitivity is a measure of the amount of contrast required to detect 
or recognize a visual target. It is a very important visual function in a person. 
Unfortunately, contrast sensitivity has been reported to decline with sustained hyper-
glycaemia. This has been attributed to retinal neurosensorial losses which may precede 
the occurrence of retinopathy in diabetic patients [51]. According to studies by Alberto 
et al. the occurrence of reduced contrast sensitivity is more in type 1 diabetic patients 
with retinopathy than with those without retinopathy [52]. Reduced contrast sensitiv-
ity can also be found in patients with type 2 diabetes. Safi et al. showed that contrast 
sensitivity decline was aggravated with the progression of retinopathy [53].
15.4 Sugar and visual field
Visual field defects have been reported as one of the notable low vision 
abnormalities that can occur in diabetic patients. Patrick and Lavin reported the 
occurrence of reversible homonymous hemianopia caused by non-ketotic hypergly-
caemia in four patients with type 2 diabetes mellitus. [54]. Their report also noted 
that among the patients, homonymous hemianopia was the first manifestation of 
diabetes mellitus type 2 in two of the patients. Other factors such cerebrovascular 
accident, coexisting glaucoma, and pan-retinal photocoagulation has been reported 
as reasons for visual field defects in diabetic patients [43].
Visual processing disorders may also be seen in diabetic patients following 
cerebrovascular accident. Processing defects such as visual neglect and extinction 
has been reported to be partially reversible in these patients following treatment, 
and interventions.
16. Role of vitreous sugar in the determination of post-mortal interval
Sugar in the vitreous has found its usefulness in forensic medicine, where it can 
be used to determine the time of death and possible causes of death. The fact that 
there are biochemical changes in the blood glucose pathway after death makes the 
use of blood glucose in the biochemical analysis of the state of a cadaver difficult 
[55]. However, this difficulty can be overcome if the vitreous humor is used, given 
that, it is better preserved after death. Use of the concentration of sugar in the 
vitreous to determine the time of death has gradually gained some level of accep-
tance in forensic medicine and has been determined to have major advantages over 
other body fluids. Some of its advantages include its accessibility and the fact that 
after death it is often protected against putrefaction.
17. Effect of low sugar intake on vision
Although most of the emphasis of the impact of sugar in the eye is often placed 
on high sugar level, however low sugar level can also be detrimental to the eye.  
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The impact of low sugar level includes blurred vision, reduced contrast sensitiv-
ity, and central scotomas [56, 57].
18. Conclusions
Sugar forms a component part of the eye. Its presence at normal concentration 
is very important for the normal visual function, however when low or high, sugar 
can have very negative impact on vision.
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